X

Trial Profile

A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 May 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Axelopran (Primary)
Indications Constipation
Focus Adverse reactions
Sponsors Theravance; Theravance Biopharma

Most Recent Events

26 Apr 2013 Results will be presented at the 32nd Annual Scientific Meeting of the American Pain Society (APS) in May 2013.
26 Apr 2013 Status changed from active, no longer recruiting to completed, as indicated in a Theravance media release.
06 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com